vs
Globe Life（GL）与因美纳（ILMN）财务数据对比。点击上方公司名可切换其他公司
Globe Life的季度营收约是因美纳的1.4倍（$1.5B vs $1.1B），Globe Life净利率更高（17.5% vs 12.3%，领先5.2%），因美纳同比增速更快（4.8% vs 3.6%），Globe Life自由现金流更多（$330.1M vs $251.0M），过去两年Globe Life的营收复合增速更高（3.6% vs -1.3%）
Globe Life Inc.（股票代码：GL）是总部位于美国得克萨斯州麦金尼的金融服务控股公司，在纽约证券交易所上市，通过旗下全资子公司开展业务，主营人寿保险、年金产品及补充健康保险产品。
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
GL vs ILMN — 直观对比
营收规模更大
GL
是对方的1.4倍
$1.1B
营收增速更快
ILMN
高出1.2%
3.6%
净利率更高
GL
高出5.2%
12.3%
自由现金流更多
GL
多$79.1M
$251.0M
两年增速更快
GL
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q1 FY2027
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.1B |
| 净利润 | $266.1M | $134.0M |
| 毛利率 | — | 66.1% |
| 营业利润率 | 21.7% | 19.2% |
| 净利率 | 17.5% | 12.3% |
| 营收同比 | 3.6% | 4.8% |
| 净利润同比 | 4.3% | — |
| 每股收益（稀释后） | $3.28 | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLILMN
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | $1.1B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.4B | $1.1B |
净利润GLILMN
| Q1 26 | — | $134.0M | ||
| Q4 25 | $266.1M | $334.0M | ||
| Q3 25 | $387.8M | — | ||
| Q2 25 | $252.7M | — | ||
| Q1 25 | $254.6M | — | ||
| Q4 24 | $255.2M | $186.0M | ||
| Q3 24 | $303.0M | $705.0M | ||
| Q2 24 | $258.4M | $-2.0B |
毛利率GLILMN
| Q1 26 | — | 66.1% | ||
| Q4 25 | — | 65.5% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 65.9% | ||
| Q3 24 | 26.1% | 69.0% | ||
| Q2 24 | 23.3% | 64.8% |
营业利润率GLILMN
| Q1 26 | — | 19.2% | ||
| Q4 25 | 21.7% | 17.4% | ||
| Q3 25 | 31.5% | — | ||
| Q2 25 | 21.2% | — | ||
| Q1 25 | 21.4% | — | ||
| Q4 24 | 21.3% | 15.8% | ||
| Q3 24 | 26.3% | 68.6% | ||
| Q2 24 | 23.5% | -147.2% |
净利率GLILMN
| Q1 26 | — | 12.3% | ||
| Q4 25 | 17.5% | 28.8% | ||
| Q3 25 | 25.6% | — | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 17.2% | — | ||
| Q4 24 | 17.4% | 16.8% | ||
| Q3 24 | 20.8% | 65.3% | ||
| Q2 24 | 17.9% | -178.8% |
每股收益（稀释后）GLILMN
| Q1 26 | — | $0.87 | ||
| Q4 25 | $3.28 | $2.16 | ||
| Q3 25 | $4.73 | — | ||
| Q2 25 | $3.05 | — | ||
| Q1 25 | $3.01 | — | ||
| Q4 24 | $3.00 | $1.16 | ||
| Q3 24 | $3.44 | $4.42 | ||
| Q2 24 | $2.83 | $-12.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $314.7M | $1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $6.0B | $2.7B |
| 总资产 | $30.8B | $6.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GLILMN
| Q1 26 | — | $1.2B | ||
| Q4 25 | $314.7M | $1.6B | ||
| Q3 25 | $62.8M | — | ||
| Q2 25 | $116.7M | — | ||
| Q1 25 | $134.1M | — | ||
| Q4 24 | $85.0M | $93.0M | ||
| Q3 24 | $100.5M | $70.0M | ||
| Q2 24 | $100.6M | $74.0M |
股东权益GLILMN
| Q1 26 | — | $2.7B | ||
| Q4 25 | $6.0B | $2.7B | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $5.4B | — | ||
| Q1 25 | $5.4B | — | ||
| Q4 24 | $5.3B | $2.4B | ||
| Q3 24 | $4.6B | $2.1B | ||
| Q2 24 | $5.2B | $1.4B |
总资产GLILMN
| Q1 26 | — | $6.6B | ||
| Q4 25 | $30.8B | $6.6B | ||
| Q3 25 | $30.5B | — | ||
| Q2 25 | $29.8B | — | ||
| Q1 25 | $29.7B | — | ||
| Q4 24 | $29.1B | $6.3B | ||
| Q3 24 | $29.6B | $6.0B | ||
| Q2 24 | $28.3B | $6.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $350.6M | $289.0M |
| 自由现金流经营现金流 - 资本支出 | $330.1M | $251.0M |
| 自由现金流率自由现金流/营收 | 21.7% | 23.0% |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 1.32× | 2.16× |
| 过去12个月自由现金流最近4个季度 | $1.3B | $1.1B |
8季度趋势，按日历期对齐
经营现金流GLILMN
| Q1 26 | — | $289.0M | ||
| Q4 25 | $350.6M | $321.0M | ||
| Q3 25 | $306.0M | — | ||
| Q2 25 | $307.9M | — | ||
| Q1 25 | $431.9M | — | ||
| Q4 24 | $336.9M | $364.0M | ||
| Q3 24 | $340.6M | $316.0M | ||
| Q2 24 | $374.1M | $80.0M |
自由现金流GLILMN
| Q1 26 | — | $251.0M | ||
| Q4 25 | $330.1M | $267.0M | ||
| Q3 25 | $208.7M | — | ||
| Q2 25 | $295.0M | — | ||
| Q1 25 | $420.1M | — | ||
| Q4 24 | $321.9M | $335.0M | ||
| Q3 24 | $311.3M | $284.0M | ||
| Q2 24 | $356.5M | $49.0M |
自由现金流率GLILMN
| Q1 26 | — | 23.0% | ||
| Q4 25 | 21.7% | 23.0% | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 19.9% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 22.0% | 30.3% | ||
| Q3 24 | 21.4% | 26.3% | ||
| Q2 24 | 24.8% | 4.4% |
资本支出强度GLILMN
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.0% | 2.6% | ||
| Q3 24 | 2.0% | 3.0% | ||
| Q2 24 | 1.2% | 2.8% |
现金转化率GLILMN
| Q1 26 | — | 2.16× | ||
| Q4 25 | 1.32× | 0.96× | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 1.22× | — | ||
| Q1 25 | 1.70× | — | ||
| Q4 24 | 1.32× | 1.96× | ||
| Q3 24 | 1.12× | 0.45× | ||
| Q2 24 | 1.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GL
| Life Segment | $849.6M | 56% |
| Health Segment | $392.3M | 26% |
| Investment Segment | $281.4M | 19% |
ILMN
| Product revenue | $917.0M | 84% |
| Service and other revenue | $174.0M | 16% |
